Latest European Association for the Study of Diabetes Stories
SAN DIEGO, June 16, 2011 /PRNewswire/ -- ProfilÂ® Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today the appointment of Dr. Andrew Krentz as Senior Director of Scientific Services. Dr.
WORCESTER, Mass., Sept.
RIDGEFIELD, Conn., Sept.
PARIS, Sept. 20 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today results of two studies presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.
DANBURY, Conn., July 1 /PRNewswire-FirstCall/ -- Biodel Inc.
JACKSONVILLE, Fla., June 29 /PRNewswire-USNewswire/ -- On June 26, 2009 several articles published online in Diabetologia by the European Association for the Study of Diabetes investigated the possible relationship between use of insulin glargine (Lantus, sanofi-aventis) and the development of certain malignancies.
The European Association for the Study of Diabetes (EASD) has announced a discovered link between French drug maker Sanofi-Aventisâ€™ Lantus diabetes drug and cancer.
WORCESTER, Mass., Oct.
A panel of experts convened by the American Diabetes Association and the European Association for the Study of Diabetes has issued updated treatment recommendations for type 2 diabetes, in a consensus statement being published online today in the journals Diabetes Care and Diabetologia.
- Large; stout; burly.